MRVI: Maravai LifeSciences Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,281.06
Enterprise Value ($M) 1,569.89
Book Value ($M) 777.39
Book Value / Share 5.49
Price / Book 1.65
NCAV ($M) 14.17
NCAV / Share 0.10
Price / NCAV 90.42

Profitability (mra)
Return on Invested Capital (ROIC) -0.09
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 9.28
Current Ratio 10.00

Balance Sheet (mrq) ($M)
Current Assets 685.36
Assets 1,447.61
Liabilities 671.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 288.94
Operating Income -28.47
Net Income -119.03

Cash Flow Statement (mra) ($M)
Cash From Operations 126.22
Cash from Investing -122.31
Cash from Financing -61.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
06-10 13G Point72 Asset Management, L.P. 5.00
05-14 13G Millennium Management Llc 5.40 18.76
02-28 13G/A 12 West Capital Management LP 8.80 0.00
02-13 13G/A Vanguard Group Inc 7.57 -3.72
02-08 13G/A Maravai Life Sciences Holdings 2, Llc 56.02 -3.15
11-07 13G/A Massachusetts Financial Services Co /ma/ 4.60 -53.57

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-09 223,356 1,525,711 14.64
2024-09-06 990,689 2,776,029 35.69
2024-09-05 316,463 1,200,227 26.37
2024-09-04 411,423 1,782,828 23.08

(click for more detail)

Similar Companies
MNMD – Mind Medicine (MindMed) Inc. MRNA – Moderna, Inc.
MRSN – Mersana Therapeutics, Inc. MTEX – Mannatech, Incorporated
MYGN – Myriad Genetics, Inc.


Financial data and stock pages provided by
Fintel.io